H Antigen Cer (d18:1/18:0) is a glycosphingolipid subtype, which can be used as an effective reference material in the research of cancer occurrence and development.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.